Published in Lancet on April 16, 1994
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol (1999) 3.66
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol (2005) 2.17
HIV prevalence, previous HIV testing, and condom use with clients and regular partners among Senegalese commercial sex workers. Sex Transm Infect (2007) 1.91
Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol (1997) 1.82
Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis (2011) 1.57
Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol (1998) 1.53
Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol (1996) 1.46
Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol (2000) 1.46
Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One (2008) 1.40
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Clin Infect Dis (2009) 1.33
The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology (2006) 1.33
Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol (2002) 1.32
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol (2001) 1.19
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS (2013) 1.13
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. J Clin Microbiol (2009) 1.12
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS (2008) 1.11
Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy. J Virol (2006) 1.10
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J Clin Microbiol (2005) 1.10
Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol (1998) 1.10
Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol (2012) 1.10
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS (2008) 1.07
Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J Virol (2004) 1.06
Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol (1998) 1.06
Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS (2006) 1.01
Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai. Indian J Med Res (2010) 0.95
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J Clin Microbiol (2008) 0.94
Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev (2001) 0.94
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology (2008) 0.93
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol (2007) 0.92
HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa. PLoS One (2011) 0.91
HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania. Genitourin Med (1995) 0.91
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One (2013) 0.91
Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J Clin Microbiol (1999) 0.90
HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal. AIDS Res Hum Retroviruses (2008) 0.89
HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners. Sex Transm Infect (1999) 0.88
Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau. Epidemiol Infect (2007) 0.88
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load. J Clin Microbiol (2014) 0.86
Engineering broadly neutralizing antibodies for HIV prevention and therapy. Adv Drug Deliv Rev (2016) 0.86
Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. J Virol (2010) 0.84
Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. Int J STD AIDS (2012) 0.84
Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection. Proc Natl Acad Sci U S A (1996) 0.83
In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci U S A (2000) 0.83
Genotypic resistance profiles of HIV-2-treated patients in West Africa. AIDS (2014) 0.82
HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts. AIDS (2013) 0.82
Viral factors in non-progression. Front Immunol (2013) 0.82
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration. PLoS One (2015) 0.81
Natural simian immunodeficiency virus transmission in mandrills: a family affair? Proc Biol Sci (2012) 0.80
HIV-2 diagnosis and quantification in high-risk patients. AIDS Res Ther (2008) 0.79
Human immunodeficiency virus type 2 infections in Austria. Wien Klin Wochenschr (2014) 0.78
Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana. Ghana Med J (2008) 0.78
Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1. AIDS (2013) 0.78
Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol (2006) 0.77
Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes. J Virol (2014) 0.77
Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection. J Virol (2008) 0.77
Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection. AIDS Res Hum Retroviruses (2012) 0.77
Molecular investigation of human immunodeficiency virus type 2 subtype a cases in South Korea. J Clin Microbiol (2006) 0.76
Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection. J Ginseng Res (2015) 0.75
An unexpected diagnosis of human immunodeficiency virus-2 infection in an overseas visitor: a case report. BMC Res Notes (2017) 0.75
Human immunodeficiency virus type 2 in two Saudi families. Ann Saudi Med (2011) 0.75
Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection. J Virus Erad (2017) 0.75
Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B. J Glob Infect Dis (2016) 0.75
Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. AIDS Patient Care STDS (2016) 0.75
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau. Clin Exp Immunol (2005) 0.75
Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner. PLoS One (2016) 0.75
Identification of Host Micro RNAs That Differentiate HIV-1 and HIV-2 Infection Using Genome Expression Profiling Techniques. Viruses (2016) 0.75
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra. J Mol Biol (2017) 0.75
Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med (1986) 11.17
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect (2003) 5.26
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Exercise intensity and longevity in men. The Harvard Alumni Health Study. JAMA (1995) 3.41
Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (1994) 3.10
Green tea and the risk of gastric cancer in Japan. N Engl J Med (2001) 2.82
Natural protection against HIV-1 infection provided by HIV-2. Science (1995) 2.54
Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol (2003) 2.40
Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst (1997) 1.98
Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care (2006) 1.97
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol (2002) 1.91
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol (1997) 1.90
Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis (1999) 1.89
Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol (2008) 1.89
Absence of leukaemia clustering on Greek islands. Lancet (1991) 1.80
Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol (2002) 1.77
Risk factors associated with the prevalence of pulmonary tuberculosis among sanitary workers in Shanghai. Tubercle (1988) 1.72
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer (2000) 1.67
Age at any birth and breast cancer risk. Int J Cancer (1983) 1.65
Effects of urban air pollutants on emergency visits for childhood asthma in Mexico City. Am J Epidemiol (1995) 1.62
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol (2001) 1.57
The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med (1998) 1.57
Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer (1993) 1.56
Vehicular traffic as a determinant of blood-lead levels in children: a pilot study in Mexico City. Arch Environ Health (1992) 1.56
Obesity and renal cell cancer--a quantitative review. Br J Cancer (2001) 1.51
Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control (1993) 1.49
Diet and coronary heart disease: a case-control study in Athens, Greece. Epidemiology (1993) 1.47
Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst (1996) 1.44
Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer (2001) 1.43
Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response. Mol Cell Biol (1996) 1.42
Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat (1996) 1.39
Low sensitivity of ELISA testing in early HIV infection. N Engl J Med (1986) 1.37
Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res (2001) 1.36
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
Time trends in physical activity among college alumni, 1962-1988. Am J Epidemiol (1992) 1.35
Building capacity for tobacco control research and policy. Tob Control (2006) 1.34
Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am J Epidemiol (1992) 1.34
Physical activity, other life-style patterns, cardiovascular disease and longevity. Acta Med Scand Suppl (1986) 1.31
High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis (2001) 1.30
Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol (2000) 1.27
Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control (1995) 1.27
Epidemiology of pancreas cancer (1988). Int J Pancreatol (1989) 1.27
Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol (1999) 1.27
Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. Int J Tuberc Lung Dis (2009) 1.26
The severity of pedestrian injuries in children: an analysis of the Pedestrian Injury Causation Study. Accid Anal Prev (1990) 1.25
A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med (1996) 1.25
Risk factors for placenta accreta. Obstet Gynecol (1999) 1.24
Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ (1996) 1.24
Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet (1993) 1.22
Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control (1995) 1.22
Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect (2001) 1.22
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer (1996) 1.21
Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA (1991) 1.20
Dietary factors and endometrial cancer risk. Results of a case-control study in Mexico. Int J Gynecol Cancer (2005) 1.19
Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res (1999) 1.17
Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol (1985) 1.17
Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology (1986) 1.16
Consumption of alcohol and tobacco and other risk factors for pancreatitis. Am J Epidemiol (1982) 1.14
Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood (1997) 1.13
Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res (1995) 1.13
Nutrient intake and cancer of the pancreas: a case-control study in Athens, Greece. Cancer Causes Control (1993) 1.12
Prevalence and distribution of cervical dentin hypersensitivity in a population in Taipei, Taiwan. J Endod (1998) 1.10
A case-control study of coronary heart disease in Athens, Greece. Int J Epidemiol (1992) 1.09
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia. Bone Marrow Transplant (1997) 1.08
Dietary factors and the risk of endometrial cancer: a case--control study in Greece. Br J Cancer (1996) 1.07
Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer (2000) 1.06
Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol (2000) 1.06
Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.06
The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci (2001) 1.05
Blood lead level and neurobehavioral development among children living in Mexico City. Arch Environ Health (1993) 1.04
Perinatal characteristics and adult mammographic patterns. Int J Cancer (1995) 1.04
Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use. Cancer (1987) 1.03
trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J Biol Chem (1993) 1.03
Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol (1992) 1.03
Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol (1987) 1.02
Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana. Genes Immun (2006) 1.01
Diagnosis of sexually transmitted infections in female prostitutes in Dakar, Senegal. Sex Transm Infect (1998) 1.01
HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS (1998) 1.01
Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors. J Microbiol Immunol Infect (2002) 1.00
Adolescent suicidal and self-destructive behavior. Results of an intervention study. J Adolesc Health Care (1986) 1.00
Environmental urban lead exposure and blood lead levels in children of Mexico City. Environ Health Perspect (1995) 0.98